GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Common Stock

Greenyn Biotechnology Co (ROCO:6846) Common Stock : NT$268.6 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Common Stock?

Greenyn Biotechnology Co's quarterly common stock increased from Sep. 2023 (NT$267.2 Mil) to Dec. 2023 (NT$268.3 Mil) and increased from Dec. 2023 (NT$268.3 Mil) to Mar. 2024 (NT$268.6 Mil).

Greenyn Biotechnology Co's annual common stock stayed the same from Dec. 2021 (NT$244.1 Mil) to Dec. 2022 (NT$244.1 Mil) but then increased from Dec. 2022 (NT$244.1 Mil) to Dec. 2023 (NT$268.3 Mil).


Greenyn Biotechnology Co Common Stock Historical Data

The historical data trend for Greenyn Biotechnology Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Common Stock Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
200.00 241.50 244.13 244.13 268.33

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 244.13 267.13 267.24 268.33 268.64

Greenyn Biotechnology Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines